Home | DEA.gov
The mission of the Drug Enforcement Administration (DEA) is to ensure the safety and health of American communities by combating criminal drug networks bringing harm, violence, overdoses, and poisonings to the United States.
Docket No. DEA-1362; A.G. Order No. 5931-2024 Schedules of Controlled Substances: Rescheduling of Marijuana AGENCY: Drug Enforcement Administration, Department of Justice. ACTION: Notice of proposed rulemaking. SUMMARY: The Department of Justice (“DOJ”) proposes to transfer marijuana from schedule
Contact Us - DEA.gov
DEA works hard to ensure that its employees serve the public with honesty, integrity, and professionalism. If you believe that a DEA employee or Task Force Officer has committed misconduct, please report it to [email protected] .
Drug Fact Sheets - DEA.gov
United States Drug Enforcement Administration DEA.gov is an official site of the U.S. Department of Justice
allegations that certain members of the Drug Enforcement Administration (DEA) have engaged in improper ex parte communications which, at least in the view of the Interlocutory Appellants, has resulted in an irrevocable taint to the proceedings.
Career Special Agent Derek S. Maltz Appointed to Lead U.S. Drug ...
Jan 21, 2025 · WASHINGTON – The Trump Administration has announced the appointment of Derek S. Maltz as Acting Administrator of the U.S. Drug Enforcement Administration. Maltz replaces Anne Milgram who departed the agency last week.
Atlanta | DEA.gov
United States Drug Enforcement Administration DEA.gov is an official site of the U.S. Department of Justice
DEA Releases 2024 National Drug Threat Assessment - DEA.gov
May 9, 2024 · WASHINGTON – Today, DEA Administrator Anne Milgram announced the release of the 2024 National Drug Threat Assessment (NDTA), DEA’s comprehensive strategic assessment of illicit drug threats and trafficking trends endangering the United States.
UNITED STATES DEPARTMENT OF JUSTICE Drug Enforcement Administration In the Matter of Schedules of Controlled Substances: Proposed Rescheduling of Marijuana DEA Docket No. 1362 Hearing Docket No. 24-44 ORDER DENYING NON-PARTICIPANT MOTION TO RECONSIDER (Watts) On January 22, 2025, Michael S. Watts (Watts), a non-Designated Participant in these
SUMMARY: The Drug Enforcement Administration (DEA) in concert with the Department of Health and Human Services (HHS) is issuing a third extension of telemedicine flexibilities for the prescribing of controlled medications, through December 31, 2025.